Population
Patients with chronic kidney disease (CKD) and hypertension
Design
Review
Authors
Loading...
Highlights pathophysiologic drivers of hypertension in CKD; leaves open targeted trials before practice change.
Management of hypertension in CKD requires individualized blood pressure targets and treatment strategies, with RAAS blockers recommended as first-line agents.
Varma et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: